Abstract:Background:Immunotherapy, chemotherapy and surgery all have significant roles in the management of small-cell lung cancer (SCLC). Neoadjuvant immunotherapy combined with chemotherapy followed by surgery has shown encouraging efficacy for resectable SCLC with a good tolerability and considerable survival benefit. However, there are still few data on whether surgery for stage I-IIIA SCLC can be performed after immunotherapy with chemotherapy. Therefore, we investigated the safety and effectiveness of neoadjuvant immunotherapy combined with chemotherapy followed by surgery in patients with stage I-IIIA SCLC in the hope of adding new ideas to the treatment of SCLC.Methods:The study group comprised 19 patients with stage I-IIIA SCLC who received neoadjuvant immunotherapy and chemotherapy between 2019 and 2021. Patients received 2-4 cycles of immunotherapy combined with platinum-containing dual-drug chemotherapy (platinum + paclitaxel) before surgery. Imaging evaluation was performed every two cycles until surgery. Tumor response to neoadjuvant therapy, neoadjuvant treatment related adverse events, perioperative and postoperative complications, surgical resection rate, and degree of tumor regression were evaluated. We obtained follow-up data from the patients' regular examination or treatment in hospital. If we can't complete it, contacting patients by telephone or WeChat would be adopted by us. The follow-up was not terminated until 3 months after surgery.Results:The objective response rate (ORR) was 84.2% (16/19), and no patients had progressive disease (PD). Of the 10 patients who underwent surgery, and approximately 9 (90.0%) had R0 resection. There were no perioperative deaths, and 1 case of pyothorax. The rate of pathological complete remission (pCR) and major pathological response (MPR) was 30.0% (3/10), and 40.0% (4/10) respectively. Grade 3-4 adverse reactions comprised 1 case of anemia and 1 case of constipation.Conclusions:Neoadjuvant immunotherapy combined with chemotherapy followed by surgical resection for patients with stage I-IIIA SCLC is effective and safe with a high ORR and MPR rate, as well as a high R0 resection rate and a tolerable toxicity profile. Whether this regimen gives a survival benefit should be confirmed by further follow-up and larger, randomized controlled trials are required to confirm our findings.

Syndrome of Inappropriate Antidiuretic Hormone Secretion in Small Cell Lung Cancer

The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors

A Narrative Review of Progress in Diagnosis and Treatment of Small Cell Lung Cancer Patients with Hyponatremia

Syndrome of Inappropriate Antidiuretic Hormone Secretion after Cranial Cerebral Injury

Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH

Syndrome of inappropriate antidiuretic hormone release as the initial presentation of adenocarcinoma of the colon

Syndrome Inappropriate ADH Secretion after Allogeneic Hematopoietic Stem Cell Transplantation:A Case Report and Literature Review

Approach to the Patients with Adrenocortical Insufficiency Combined with the Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Small cell lung cancer with panhypopituitarism due to ectopic adrenocorticotropic hormone syndrome: A case report

Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin

Central diabetes insipidus: A rare primary manifestation of small-cell lung carcinoma

Safety and Effectiveness of Neoadjuvant Immunotherapy Combined with Chemotherapy Followed by Surgical Resection in Patients with Stage I-IIIA Small-Cell Lung Cancer: a Retrospective Single-Arm Clinical Trial.

A multi-parameter study of the etiological diagnosis of hyponatremia after hypothalamic tumor surgery

Current Small Cell Lung Cancer Treatment In China

Current Diagnosis and Management of Small-Cell Lung Cancer

[A Case of Consciousness Disorder Induced by the Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Cisplatin and 5-Fluorouracil Chemotherapy in a Patient with Tongue Cancer]

Advances in antiangiogenic treatment of small-cell lung cancer

Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus A case report

Progress in research of cerebral salt wasting syndrome

Capillary Leak Syndrome Associated with Anaplastic T Cell Lymphoma and Transcutaneous Exudation: An Unusual Presentation

Whole-Process Treatment of Combined Small Cell Lung Cancer Initially Diagnosed As “lung Squamous Cell Carcinoma”: A Case Report and Review of the Literature